Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

GreenMark Biomedical

Explore full profile

Minimally invasive healthcare company

East Lansing, United StatesFounded 2016Biotech & Life Sciences
Valuation <$5M Last recorded · 2022
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for GreenMark Biomedical and the history behind them.

About GreenMark Biomedical

GreenMark Biomedical Inc. operates as a minimally invasive healthcare company, positioning itself at the intersection of biotechnology and dental care. Founded in Michigan in 2016 by Dr. Steven Bloembergen, the firm's mission is to enable oral healthcare professionals to preserve teeth through early diagnosis and less invasive treatment options. Dr. Bloembergen, who serves as Chairman and CEO, brings over three decades of experience in biomaterials development and commercialization. His journey includes founding EcoSynthetix in 1996, a company that became a global manufacturer of bio-based nanoparticles and where the foundational technology for GreenMark was developed through a network of university collaborations. This prior venture culminated in a successful IPO on the Toronto Stock Exchange in 2011.

The company's core technology, developed in partnership with the University of Michigan, revolves around bioresorbable starch nanoparticles. These food-grade particles act as carriers for dental applications and are naturally degraded by enzymes in saliva. GreenMark's business model focuses on developing and commercializing a suite of products for dental professionals that address the prevalent issue of dental caries, or tooth decay. The company generates revenue through the sale of these products to dental clinics and professionals.

A key product is the LumiCare™ Caries Detection Rinse, which received FDA 510(k) clearance as a Class II Medical Device in April 2021. This prescription-use rinse contains fluorescently labeled starch particles that penetrate the porous subsurface of early-stage carious lesions. When a standard dental curing light is used, these particles illuminate the affected areas, enhancing visualization of pre-cavities that might otherwise be undetectable. The particles are designed to be bio-resorbed by the time a patient's appointment is over. Another product, CrystLCare™ Biorestorative, is a fluoride-free dental strip for treating sensitivity. It uses the same nanoparticle technology to deliver minerals like calcium and phosphate to block exposed dentinal tubules, providing long-lasting relief.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
East Lansing, United States
Sector
Biotech & Life Sciences

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed8 investors entered at this stage

  • Blue Water Angels
  • Red Cedar Ventures
  • ID Ventures
  • Bluewater
  • University of Michigan
  • Michigan Rise
  • National Institutes of Health
  • Translational Resource Center

Series A1 investor entered at this stage

  • Gaorong Ventures
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about GreenMark Biomedical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GreenMark Biomedical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.